FDA Approved: TOBRADEX — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for TOBRADEX (tobramycin and dexamethasone) to update the ophthalmic label for inflammatory and infectious eye condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• Tobradex (tobramycin and dexamethasone)

Snippet

SUPPL AP for TOBRADEX (TOBRAMYCIN AND DEXAMETHASONE)